This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...

A study on Ozempic for weight loss reveals user satisfaction is driven by efficacy, despite common gastrointestinal side ...

Other research has since tied GLP-1 receptor agonists to other eye conditions, including age-related macular degeneration and diabetic retinopathy. Conversely, some data have shown a benefit; one ...

Many semaglutide (e.g., Ozempic) users keep taking the drug because they see real weight loss or appetite reduction.  A Rutgers study analyzed anon ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

A new study suggests that people taking semaglutide for weight loss, including the brand Ozempic, are often willing to ...

Presented by the Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care The Big Story Legal pressures ...

Newer weight loss medications have helped many people lose a large amount of weight in a short time. Drugs such as ...

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling ...